
Publikationen von Kati Turkowski
Alle Typen
Zeitschriftenartikel (9)
2024
Zeitschriftenartikel
miR-147b mediated suppression of DUSP8 promotes lung cancer progression. ONCOGENE (2024)
2023
Zeitschriftenartikel
83 (14), S. 2345 - 2357 (2023)
The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization. CANCER RESEARCH 2022
Zeitschriftenartikel
13 (1), 6078 (2022)
Fibrocytes boost tumor-supportive phenotypic switches in the lung cancer niche via the endothelin system. NATURE COMMUNICATIONS 2021
Zeitschriftenartikel
13 (2), 208 (2021)
Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of Versican. CANCERS 2020
Zeitschriftenartikel
9 (8), 1755 (2020)
Fibroblast Growth Factor-14 Acts as Tumor Suppressor in Lung Adenocarcinomas. CELLS 2018
Zeitschriftenartikel
8, 12471 (2018)
Repurposing Thioridazine (TDZ) as an anti-inflammatory agent. SCIENTIFIC REPORTS
Zeitschriftenartikel
66 (1), S. 161 - 174 (2018)
VEGF as a modulator of the innate immune response in glioblastoma. GLIA
Zeitschriftenartikel
197 (2018)
Macrophage and Cancer Cell Crosstalk Regulated MicroRNA 147b Plays a Crucial Role in Lung Cancer Progression. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2017
Zeitschriftenartikel
8 (29), S. 48436 - 48452 (2017)
Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy. ONCOTARGET